Does ALGLUCOSIDASE ALFA Cause Nephrolithiasis? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Nephrolithiasis have been filed in association with ALGLUCOSIDASE ALFA (Lumizyme). This represents 0.4% of all adverse event reports for ALGLUCOSIDASE ALFA.
11
Reports of Nephrolithiasis with ALGLUCOSIDASE ALFA
0.4%
of all ALGLUCOSIDASE ALFA reports
0
Deaths
6
Hospitalizations
How Dangerous Is Nephrolithiasis From ALGLUCOSIDASE ALFA?
Of the 11 reports, 6 (54.5%) required hospitalization.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALGLUCOSIDASE ALFA. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does ALGLUCOSIDASE ALFA Cause?
Pyrexia (266)
Off label use (210)
Dyspnoea (203)
Inappropriate schedule of product administration (190)
Pneumonia (185)
Malaise (130)
Respiratory failure (128)
Fatigue (122)
Death (120)
Disease progression (111)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which ALGLUCOSIDASE ALFA Alternatives Have Lower Nephrolithiasis Risk?
ALGLUCOSIDASE ALFA vs ALIMTA
ALGLUCOSIDASE ALFA vs ALIROCUMAB
ALGLUCOSIDASE ALFA vs ALISKIREN
ALGLUCOSIDASE ALFA vs ALISKIREN HEMIFUMARATE
ALGLUCOSIDASE ALFA vs ALISKIREN\HYDROCHLOROTHIAZIDE